EN DE

Lykis Limited (LYKISLTD) Fair Value & Analysis

Consumer Defensive · IN · Market cap ₹862M

LL Lykis Limited LYKISLTD · BSE
Price₹51.97
Fair Value₹56.68
Upside+9.1%
Quality47/100
Watch Lykis Limited for free, get notified when fair value or trend changes. Watch for free

Strengths

Ranks above peers (8/12)

Risks

!Expensive Growth
!Thin margins · 1.7% net margin
!Low debt · negative free cash flow
!Narrow moat 36/100
Expensive Growth
Thin margins · 1.7% net margin
Low debt · negative free cash flow
Ranks above peers (8/12)
Narrow moat 36/100
Evidence: High Range ₹42.51 – ₹70.85 Share as image

Fair value as of: Aug 13, 2026

From 15 valuation models · updated 9 days ago

Below-average quality, currently priced close to our fair value.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Our model range runs from ₹42.51 (bear) to ₹70.85 (bull), base ₹56.68. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 47/100 (below-average quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

₹131.95 ₹23.05 Fair Value ₹56.68 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range ₹23.05 – ₹131.95 · fair‑value band ₹42.51 – ₹70.85 · the ₹51.97 price screens below the ₹56.68 fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Lykis Limited (LYKISLTD) currently trades at ₹51.97, while our model-based Fair Value estimate is ₹56.68, implying the stock looks roughly 9.1% fairly valued today. The Quality Score stands at 47/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Lykis Limited generated revenue of ₹3.9B at a net margin of 1.7%. Revenue grew 136.6% year over year. It earns a return on equity of 17.3%. Net debt stands at ₹978M. Fundamentals as of Aug 13, 2026

Our scenario range runs from ₹42.51 (bear case) to ₹70.85 (bull case); at ₹51.97, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 16% below its 52-week high and 78% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -38% fair-value upside, at 9%, LYKISLTD screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
ROIC Compounder ₹45.81 ₹60.67 ₹79.77 72
Growth-Adj P/E ₹63.34 ₹90.49 ₹117.63 68
P/E Multiple ₹52.64 ₹70.18 ₹87.73 63
All 15 models by family
DCF Models
Owner Earnings ₹54.42 ₹107.93 ₹206.54 31
Earnings-Based
Graham-Dodd ₹22.73 ₹156.52 ₹219.54 54
Lynch FV ₹46.09 ₹65.84 ₹85.59 50
PEG = 1.0 ₹46.09 ₹65.84 ₹85.59 46
EPV ₹39.05 ₹43.87 ₹47.88 59
Multiples
P/E Multiple ₹52.64 ₹70.18 ₹87.73 63
P/S Multiple ₹42.61 ₹56.81 ₹71.02 58
P/B Multiple ₹42.61 ₹56.81 ₹71.02 55
EV/EBIT ₹66.27 ₹87.11 ₹107.95 53
EV/EBITDA ₹58.25 ₹76.42 ₹94.59 54
EV/Revenue ₹48.37 ₹67.50 ₹86.62 43
Asset-Based
NCAV (Graham) ₹10.53 ₹14.11 ₹21.06 50
Economic Profit
Residual Income ₹20.23 ₹25.49 ₹59.78 61
ROIC Compounder ₹45.81 ₹60.67 ₹79.77 72
Growth Earnings
Growth-Adj P/E ₹63.34 ₹90.49 ₹117.63 68

Widest divergence: DCF Models (₹107.93) versus Asset-Based (₹14.11). Highest evidence: ROIC Compounder (72).

Notify me when LYKISLTD reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) ₹3.9B
Revenue growth (YoY) +137%
Net margin 1.7%
Return on equity 17.3%
Free cash flow −₹322M FY2026
P/E ratio 15.6
More key figures
Operating margin 2.8%
EPS (TTM) ₹3.34
EPS growth (YoY) +27.5%
Net debt ₹978M FY2026

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 47/100

Of which business quality 43 · Market factors (momentum, volatility) 59

Profitability 51
Margins and returns on capital today
Quality Growth 58
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 26
Balance sheet, leverage, solvency risk
Investment 75
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 59
Price trend over the last 3–12 months (market factor)
52W Momentum 68
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Lykis Limited engages in the fast moving consumer goods (FMCG) business in India and internationally. The company provides personal care products including skin care products, such as creams, face wash, body oil, lotion, shower gel, masks, face and body scrub, hair removal cream, petroleum jelly, body butter, talc, intimate wash, petroleum jelly, and hand …

Full company description

Lykis Limited engages in the fast moving consumer goods (FMCG) business in India and internationally. The company provides personal care products including skin care products, such as creams, face wash, body oil, lotion, shower gel, masks, face and body scrub, hair removal cream, petroleum jelly, body butter, talc, intimate wash, petroleum jelly, and hand wash; hair care products comprising shampoo, spray, conditioner, base cream, hair food and relaxer, oil, detox mask, cleansing liquid, hair colour and milk, pomade, and gels; toothpaste; soaps; deodorant, perfume, and body mist; and baby cream, oil, shampoo, talc, wipes, and diaper. It also offers FMCG products, including biscuits and cookies; confectionery, such as candy, lollipops, and toffees; commodity products comprising hot pots, stock pots, utensils, footwear, liquor, and others; and other OTC products. The company provides its products under the Lykis, H&H, Rox, Bonita, Monami, Special, Lykon, Bentol, Stylo, Bon Fami, Calmon, Bon Dejeuner, Mellar, Bom Dia, Blue Fins, Bon Appetit, Senhorita, Polo Star, Leopard, Elephant, Carnoba, Classic, Maria, Spectra, Flite, Bahamas, Sparx, Metro, Cipro, Para, Dextrose and Water for Injection, Davigra, Dermogerme, A-DEM, Candicyl, Rectostop-HC, Nystatine, and Davimov brands. It also exports its products. Lykis Limited was formerly known as Greenline Tea & Exports Limited and changed its name to Lykis Limited in July 2012. The company was incorporated in 1984 and is headquartered in Mumbai, India.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Lykis Limited reported revenue of ₹3.9B in FY2026 versus ₹3.2B in FY2022, a compound +4.7%/yr. Reported net income was ₹64.8M in FY2026, compounding +27.9%/yr from FY2022.

Growth Quality 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2026)
₹3.9B
Latest YoY
+33.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−4.5%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+46.9%
Avg. growth/yr (7Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+14.9%
Revenue +4.7%/yr
FY22 ₹3.2B
FY23 ₹4.5B
FY24 ₹4.0B
FY25 ₹2.9B
FY26 ₹3.9B
Net income +27.9%/yr
FY22 ₹24.2M
FY23 ₹157M
FY24 ₹38.8M
FY25 ₹26.1M
FY26 ₹64.8M

Watch LYKISLTD: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Lykis Limited Fair Value". https://www.fairvalue-calculator.com/stock/LYKISLTD

Peer Group

Household & Personal Products · 250 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 47 · Bottom 25%
Fair Value upside +9% · Above median
Return on equity (TTM) 17% · Top 25%
Return on assets 4% · Above median
Net margin (TTM) 2% · Below median
Operating margin (TTM) 3% · Below median
Revenue growth 137% · Top 25%

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/E (TTM) 15.6× · Cheaper than median
P/B 2.11× · Pricier than median
P/S (TTM) 0.22× · Cheaper than 75% of peers
EV/EBITDA 8.7× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE45 · sector 27
FUTURE100 · sector 4
PAST69 · sector 27
HEALTH100 · sector 98
DIVIDEND0 · sector 53

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $144.26 $108.16 -25%
Unilever PLC ULN 1,080 MXN 973.58 MXN -10%
Hindustan Unilever Limited HINDUNILVR ₹2,015 ₹789.46 -61%
Essity AB ESSITYA kr 273.00 kr 250.02 -8%
Godrej Consumer Products Limited GODREJCP ₹936.90 ₹367.64 -61%
Marico Limited MARICO ₹853.40 ₹233.20 -73%
APR Co 278470 396,500 KRW 137,521 KRW -65%
Dabur India Limited DABUR ₹411.25 ₹175.59 -57%
PT Unilever Indonesia Tbk UNVR 1,795 IDR 1,928 IDR +7%
Amorepacific Corporation 090430 135,700 KRW 84,785 KRW -38%

Compare Lykis Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Discover undervalued stocks

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Evidence & backtest 34 years, survivorship-adjusted Financial calculators DCF, Graham, PEG and more

Frequently asked questions

Is Lykis Limited (LYKISLTD) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of ₹56.68 versus a price of ₹51.97, about +9% (fairly valued).
What is the fair value of LYKISLTD?
Our model-based fair value for Lykis Limited is ₹56.68 (as of Aug 13, 2026), built from audited fundamentals. The current price: ₹51.97.
What is the quality score of LYKISLTD?
Lykis Limited has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Lykis Limited (LYKISLTD)?
Lykis Limited reported trailing-twelve-month revenue of about ₹3.9B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of LYKISLTD?
The net profit margin of Lykis Limited is about 1.7%, meaning it keeps roughly 1.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Lykis Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.